iCAD and Densitas enter into a strategic partnership


iCAD and Densitas have announced a strategic partnership to expand their AI breast portfolio. The collaboration aims to improve mammography quality, cancer detection and risk assessment by integrating iCAD's ProFound AI technology with Densitas' intelliMammo platform. The partnership will enable the full spectrum of a woman's breast health journey to be covered, from quality screening, detection and density assessment to comprehensive risk evaluation. This initiative aims to leverage leading AI solutions to drive precision in breast health services.